tiprankstipranks
Avanos Medical, Inc. (AVNS)
:AVNS
US Market

Avanos Medical (AVNS) Earnings Dates, Call Summary & Reports

Compare
168 Followers

Earnings Data

Report Date
Apr 30, 2025
TBA Not Confirmed
Period Ending
2025 (Q1)
Consensus EPS Forecast
0.18
Last Year’s EPS
0.19
Same Quarter Last Year
Based on 2 Analysts Ratings
---

Earnings Call Summary

Earnings Call Date:Feb 26, 2025
|
% Change Since: -3.28%
|
Next Earnings Date:Apr 30, 2025
Earnings Call Sentiment|Neutral
The earnings call presented a mixed sentiment. The company achieved strong performance in its enteral feeding portfolio and improved its financial position significantly. However, these positive outcomes were offset by a substantial non-cash impairment charge and challenges in the pain management and recovery portfolio. Additionally, the outlook for 2025 indicates a pause in margin improvement and flat sales expectations.
Company Guidance
During the fourth quarter of 2024, Avanos Medical, Inc. reported sales from continuing operations of approximately $180 million, an organic sales increase of 5% year-over-year, and adjusted diluted earnings per share of $0.43. The company achieved an adjusted EBITDA of nearly $29 million, with adjusted gross margins close to 59% and SG&A expenses accounting for 41.6% of revenue. For the full year, sales from continuing operations totaled around $688 million, marking a 3.3% organic sales increase, and adjusted diluted earnings per share rose by 31% to $1.35. The adjusted EBITDA reached approximately $108 million, and free cash flow generation was $83 million, significantly up from the previous year. The guidance for 2025 forecasts net sales between $665 million and $685 million, with the Specialty Nutrition Systems segment expected to grow mid-single digits and the Pain Management and Recovery segment anticipated to achieve flat to low single-digit growth. Adjusted diluted earnings per share are projected to range from $1.05 to $1.25, with an effective tax rate of about 27%.
Strong Fourth Quarter Performance
Sales from continuing operations during the fourth quarter were approximately $180 million, with organic sales up 5% compared to a year ago. Adjusted diluted earnings per share were $0.43, and adjusted EBITDA from continuing operations was nearly $29 million.
Enteral Feeding Portfolio Growth
The enteral feeding portfolio grew almost 12% organically versus the prior year, reaffirming its number one position in short-term, long-term, and neonatal feeding.
Improved Financial Position and Liquidity
The company improved its financial position with $108 million of cash on hand and $135 million of debt outstanding by the end of the year, and generated $83 million of free cash flow, an increase of almost $70 million compared to the previous year.
Successful Transformation Initiatives
The company completed the divestiture of its respiratory health business and exited the deferred prosecution agreement with the DOJ, marking significant milestones in its three-year transformation process.
---

Avanos Medical (AVNS) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

AVNS Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Apr 30, 20252025 (Q1)
0.18 / -
0.19
Feb 26, 20252024 (Q4)
0.40 / 0.43
0.3619.44% (+0.07)
Oct 30, 20242024 (Q3)
0.35 / 0.33
0.3077.49% (+0.02)
Jul 31, 20242024 (Q2)
0.29 / 0.29
0.23125.54% (+0.06)
May 02, 20242024 (Q1)
0.21 / 0.19
0.27-29.63% (-0.08)
Feb 20, 20242023 (Q4)
0.37 / 0.36
0.6-40.00% (-0.24)
Nov 01, 20232023 (Q3)
0.28 / 0.31
0.38-19.21% (-0.07)
Aug 09, 20232023 (Q2)
0.30 / 0.23
0.41-43.66% (-0.18)
May 03, 20232023 (Q1)
0.28 / 0.27
0.263.85% (+0.01)
Feb 21, 20232022 (Q4)
0.49 / 0.60
0.4630.43% (+0.14)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---

AVNS Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Feb 26, 2025$15.56$15.62+0.39%
Oct 30, 2024$22.63$18.58-17.90%
Jul 31, 2024$22.96$23.92+4.18%
May 02, 2024$18.79$19.71+4.90%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---

FAQ

When does Avanos Medical, Inc. (AVNS) report earnings?
Avanos Medical, Inc. (AVNS) is schdueled to report earning on Apr 30, 2025, TBA Not Confirmed.
    What is Avanos Medical, Inc. (AVNS) earnings time?
    Avanos Medical, Inc. (AVNS) earnings time is at Apr 30, 2025, TBA Not Confirmed.
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is AVNS EPS forecast?
          AVNS EPS forecast for the fiscal quarter 2025 (Q1) is 0.18.
            ---
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis